Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease

Davide Lombardi, Davide Mattavelli, Luca O. Redaelli De Zinis, Remo Accorona, Maria L. Morassi, Fabio Facchetti, Vittorio Ferrari, Davide Farina, Rossella Bertulli, Piero Nicolai

Research output: Contribution to journalArticlepeer-review


Background: Sinonasal localization of Ewing's sarcoma in adults is an exceedingly rare event. Methods: The clinical records of 5 patients with primary sinonasal Ewing's sarcoma treated from 1992 to 2012 were retrospectively analyzed. All pathologic slides were reviewed by 2 experienced pathologists. All patients underwent multimodality treatments. Results: Median age was 36 years (range, 25–52 years). At referral, 2 patients had the original diagnosis changed by review of the histologic slides. Tumors were classified as T4aN0M0 (4 patients) and T2N0M0 (1 patient). Median follow-up was 110 months (range, 70–139 months). Only 1 patient, who started treatment elsewhere based on an incorrect histologic diagnosis, experienced multiple recurrences and eventually died of widespread metastasis. Conclusion: Correct pathologic diagnosis can have a crucial impact on treatment planning and outcome. Multimodality therapy is the key for long-term successful results. Because of the rarity of the tumor, referral to highly experienced care centers is strongly recommended.

Original languageEnglish
Pages (from-to)E45-E50
JournalHead and Neck
Issue number3
Publication statusPublished - Mar 1 2017


  • chemotherapy
  • Ewing's sarcoma
  • multimodality treatment
  • sinonasal cancer
  • transnasal endoscopic surgery

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease'. Together they form a unique fingerprint.

Cite this